Literature DB >> 28939071

Intraindividual homogeneity of 18F-FDG PET/CT parameters in HPV-positive OPSCC.

Shachi Jenny Sharma1, Claus Wittekindt2, Jennifer Knuth2, Dagmar Steiner3, Nora Wuerdemann2, Maren Laur4, Tobias Kroll2, Steffen Wagner2, Jens Peter Klussmann2.   

Abstract

OBJECTIVES: 18F-FDG PET/CT is widely used in clinical oncology. Human papillomavirus (HPV)-related oropharyngeal squamous cell carcinoma (OPSCC) represents an emerging disease that differs from HPV-negative OPSCC in clinical behavior and tumour biology. In these tumours, HPV-oncogenes might lead to distinct alterations in metabolic pathways. Therefore, we compared metabolic parameters using 18F-FDG PET/CT in HPV-positive and HPV-negative OPSCC in relation to histopathological findings. MATERIALS: Eighty-six patients with OPSCC received pre-therapeutic 18F-FDG PET/CT. Standardised uptake volume (SUV), total lesion glycolysis (TLG) and metabolic tumour volume (MTV) were analysed for the primary tumour. SUVmax was determined for neck lymph nodes. HPV-status was determined; overall survival rates (OS) were estimated.
RESULTS: 32/86 patients (37.2%) had HPV-related OPSCC. Overall, PET-parameters in primary tumours of both groups did not differ significantly. Comparing early with locally advanced primary tumours, there was a significant increase in 18F-FDG uptake in HPV-negative patients (p<0.001). Positive nodes of HPV-related OPSCC showed significantly higher SUVmax values (p=0.039) compared to HPV-negative OPSCC. Strikingly, there was a higher intraindividual homogeneity of 18F-FDG uptake between primary and respective positive nodes in HPV-related primary OPSCC (p=0.001). SUV-max and -mean values did not correlate with OS in HPV-related OPSCC.
CONCLUSION: The intraindividual homogeneity of 18F-FDG uptake in HPV-related OPSCC could reflect the more homogenously, HPV-triggered carcinogenesis compared to the mutation-driven carcinogenesis in the HPV-negative OPSCC with heterogenic 18F-FDG uptake.
Copyright © 2017 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Glycolysis; HPV; Hypoxia; Metabolism; Oropharyngeal cancer; PET-CT; Squamous cell carcinoma

Mesh:

Substances:

Year:  2017        PMID: 28939071     DOI: 10.1016/j.oraloncology.2017.08.019

Source DB:  PubMed          Journal:  Oral Oncol        ISSN: 1368-8375            Impact factor:   5.337


  4 in total

Review 1.  [The innate immune system in oropharyngeal squamous cell carcinoma : Immune modulation by HPV].

Authors:  S Wagner; H Böckmann; S Gattenlöhner; J P Klussmann; C Wittekindt
Journal:  HNO       Date:  2018-04       Impact factor: 1.284

Review 2.  Advances in Imaging for HPV-Related Oropharyngeal Cancer: Applications to Radiation Oncology.

Authors:  Travis C Salzillo; Nicolette Taku; Kareem A Wahid; Brigid A McDonald; Jarey Wang; Lisanne V van Dijk; Jillian M Rigert; Abdallah S R Mohamed; Jihong Wang; Stephen Y Lai; Clifton D Fuller
Journal:  Semin Radiat Oncol       Date:  2021-10       Impact factor: 5.421

3.  Prognostic value of simultaneous 18F-FDG PET/MRI using a combination of metabolo-volumetric parameters and apparent diffusion coefficient in treated head and neck cancer.

Authors:  Yong-Il Kim; Gi Jeong Cheon; Seo Young Kang; Jin Chul Paeng; Keon Wook Kang; Dong Soo Lee; June-Key Chung
Journal:  EJNMMI Res       Date:  2018-01-10       Impact factor: 3.138

4.  Usefulness of Hybrid PET/MRI in Clinical Evaluation of Head and Neck Cancer Patients.

Authors:  Natalia Samolyk-Kogaczewska; Ewa Sierko; Dorota Dziemianczyk-Pakiela; Klaudia Beata Nowaszewska; Malgorzata Lukasik; Joanna Reszec
Journal:  Cancers (Basel)       Date:  2020-02-22       Impact factor: 6.639

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.